GMP is an unofficial indicator of investor demand before listing — not a guaranteed outcome.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions.
Goldline Pharmaceutical IPO.
Pharmaceutical & Drugs & Healthcare — Sme IPO listing on BSE
12 May - 14 May 2026
Fixed Price IPO
Fresh Capital
- Price Band
- ₹ 41 – 43
- Lot Size
- 3000
- Issue Size
- ₹12 Cr
- Minimum Investment
- ₹258000 (6000 Shares)
- Listing Date
- 19 May 2026
Grey Market Premium
₹62
▲ 24.6% over cap
| As On | Issue Price | GMP | Esti. Listing |
|---|---|---|---|
| 19 May 2026 | ₹43.00 | ₹15 | ₹58 |
| 18 May 2026 | ₹43.00 | ₹15 | ₹58 |
| 17 May 2026 | ₹43.00 | ₹20 | ₹63 |
| 16 May 2026 | ₹43.00 | ₹20 | ₹63 |
| 15 May 2026 | ₹43.00 | ₹20 | ₹63 |
| 14 May 2026 | ₹43.00 | ₹15 | ₹58 |
| 13 May 2026 | ₹43.00 | ₹25 | ₹68 |
| 12 May 2026 | ₹43.00 | ₹18 | ₹61 |
| 11 May 2026 | ₹43.00 | ₹17 | ₹60 |
| 10 May 2026 | ₹43.00 | ₹16 | ₹59 |
| 09 May 2026 | ₹43.00 | ₹15 | ₹58 |
| 08 May 2026 | ₹43.00 | ₹8 | ₹51 |
| 07 May 2026 | ₹43.00 | ₹0 | ₹43 |